Even After a $46 Billion Plunge, China's Drugmakers May Have a Long Way to Fall

(Bloomberg) -- Even after a plunge last month that wiped $46 billion off Chinese health-care stocks, domestic drugmakers may be far from their floor as a Beijing-led policy shift gathers pace.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.